Skip to content

Allergan

Latest Stories

3cdbf7cb9921f412530f6a706700a591.jpg

3cdbf7cb9921f412530f6a706700a591.jpg

FILE - This Feb. 6, 2012, file photo, shows William Ackman, of Pershing Square Capital Management, in Toronto. It was announced Monday, May 12, 2014, that Botox maker Allergan is rejecting a takeover bid from Valeant Pharmaceuticals, saying that the unsolicited bid worth nearly $46 billion undervalues the company and carries significant risk. Shortly after Canada’s Valeant and activist investor Ackman made their offer public last month, Allergan announced a so-called poison pill plan, a defensive tactic that makes a buyout prohibitively expensive. (AP Photo/The Canadian Press, Pawel Dwulit, File)

FDA_Obesity_Treatments.sff.jpg

FDA_Obesity_Treatments.sff.jpg

In this product photograph provided by Allergan, Inc., the LAP-BAND System is displayed. An FDA panel will vote whether to recommend expanding the use of a stomach shrinking band currently approved just for the morbidly obese. (AP Photo/Allergan, Inc.) NO SALES